marketcap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-23-2025
Medpace Holdings DSO Ratio 2011-2025 | MEDP
Annual DSO Ratio Medpace Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.5 | 53.4 | 55 | 55.5 | 62.4 | 66 | 69.1 | 69.5 | 69.1 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 69.5 | 51.5 | 61.3 |
Quarterly DSO Ratio Medpace Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.9 | 51.1 | 48.6 | - | 52.4 | 50.1 | 51.6 | - | 52.6 | 52.8 | 53.7 | - | 29.6 | 29.2 | 56.7 | - | 53.7 | 52.7 | 56.3 | - | 63.8 | 71.7 | 62.6 | 61.8 | 65.7 | 66.3 | 65.7 | 63.4 | 67.9 | 71.6 | 60.6 | 67.3 | 68.5 | 71.4 | 69.7 | - | 67.5 | 68.7 | 66.4 | - | 32.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 71.7 | 29.2 | 58.1 |
DSO Ratio of other stocks in the Diagnostics research industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
145 | $ 0.33 | -6.23 % | $ 30.6 M |  Germany |
 |
Fluidigm Corporation
FLDM
|
67.2 | $ 3.75 | 1.08 % | $ 308 M |  USA |
 |
Global Cord Blood Corporation
CO
|
112 | $ 2.99 | - | $ 399 M |  China |
 |
Oxford Immunotec Global PLC
OXFD
|
90.8 | $ 21.99 | - | $ 562 M |  Britain |
 |
Genetron Holdings Limited
GTH
|
122 | $ 4.03 | 0.12 % | $ 80.1 M | China |
 |
Chembio Diagnostics
CEMI
|
66.3 | $ 0.46 | 0.22 % | $ 16.8 M | USA |
 |
Meridian Bioscience
VIVO
|
55.2 | $ 33.97 | - | $ 1.49 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
101 | $ 0.48 | -20.0 % | $ 1.06 M | USA |
 |
Quotient Limited
QTNT
|
45.1 | $ 0.32 | -11.32 % | $ 1.1 M |  Schweiz |
 |
Bioventus
BVS
|
92.3 | $ 7.41 | 0.34 % | $ 464 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
98.1 | $ 165.21 | - | $ 10.7 B | USA |
 |
Heska Corporation
HSKA
|
40.8 | $ 119.99 | - | $ 1.31 B | USA |
 |
Motus GI Holdings
MOTS
|
77.2 | $ 0.17 | -34.28 % | $ 263 K |  Israel |
 |
Biocept
BIOC
|
112 | $ 0.43 | -13.05 % | $ 7.29 M | USA |
 |
Syneos Health
SYNH
|
111 | $ 42.98 | - | $ 4.46 B | USA |
 |
Invitae Corporation
NVTA
|
242 | $ 0.09 | - | $ 21.2 M | USA |
 |
DermTech
DMTK
|
80.6 | $ 0.09 | -11.32 % | $ 2.94 M | USA |
|
Akumin
AKU
|
57.4 | $ 0.29 | -17.87 % | $ 25.9 M |  Canada |
 |
Castle Biosciences
CSTL
|
49.2 | $ 33.7 | 0.39 % | $ 936 M | USA |
 |
DarioHealth Corp.
DRIO
|
85.8 | $ 12.58 | -7.4 % | $ 357 M | Israel |
 |
PerkinElmer
PKI
|
87.6 | $ 115.24 | -0.91 % | $ 14.7 B | USA |
 |
OpGen
OPGN
|
4.66 | $ 1.96 | -16.95 % | $ 1.54 M | USA |
 |
DexCom
DXCM
|
85 | $ 58.14 | -1.92 % | $ 22.4 B | USA |
 |
Neogen Corporation
NEOG
|
66.6 | $ 5.98 | -3.78 % | $ 1.3 B | USA |
 |
Organovo Holdings
ONVO
|
79.8 | $ 2.12 | -2.3 % | $ 19.4 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
31.7 | $ 12.25 | 0.41 % | $ 133 M | China |
 |
Pacific Biosciences of California
PACB
|
50.4 | $ 1.78 | -7.03 % | $ 451 M | USA |
 |
Danaher Corporation
DHR
|
57 | $ 211.38 | -0.39 % | $ 155 B | USA |
 |
Biomerica
BMRA
|
57.7 | $ 2.55 | -1.16 % | $ 5.86 M | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 22.23 | -2.41 % | $ 672 M | USA |
 |
Thermo Fisher Scientific
TMO
|
69.9 | $ 566.14 | -0.28 % | $ 216 B | USA |
 |
Psychemedics Corporation
PMD
|
61.3 | $ 2.67 | -1.84 % | $ 15.3 M | USA |
 |
Trinity Biotech plc
TRIB
|
87.2 | $ 0.98 | -1.5 % | $ 61.9 M |  Irlanda |
 |
Genetic Technologies Limited
GENE
|
11.7 K | $ 0.77 | - | $ 7.1 B |  Australia |
 |
Twist Bioscience Corporation
TWST
|
46 | $ 30.5 | -3.24 % | $ 1.77 B | USA |
 |
Myriad Genetics
MYGN
|
51.3 | $ 6.38 | -3.12 % | $ 578 M | USA |
 |
Renalytix AI plc
RNLX
|
15.9 | $ 0.21 | 5.66 % | $ 22.7 M | Britain |
 |
Quidel Corporation
QDEL
|
116 | $ 21.75 | -20.55 % | $ 916 M | USA |
 |
IQVIA Holdings
IQV
|
78 | $ 212.13 | 0.96 % | $ 38.5 B | USA |
 |
CareDx, Inc
CDNA
|
76.4 | $ 14.89 | -9.95 % | $ 801 M | USA |
 |
Exagen
XGN
|
43.9 | $ 10.63 | 2.9 % | $ 188 M | USA |
|
Biodesix
BDSX
|
41.7 | $ 7.84 | -8.84 % | $ 1.02 B | USA |
 |
T2 Biosystems
TTOO
|
91.3 | $ 0.12 | -39.35 % | $ 313 K | USA |
 |
OPKO Health
OPK
|
240 | $ 1.38 | 2.99 % | $ 958 M | USA |
 |
Guardant Health
GH
|
49.2 | $ 96.58 | 1.61 % | $ 11.9 B | USA |
 |
Agilent Technologies
A
|
63.8 | $ 147.55 | 0.53 % | $ 44.9 B | USA |
 |
Co-Diagnostics
CODX
|
101 | $ 0.4 | 0.84 % | $ 11.7 M | USA |